Michael S Anderson - Net Worth and Insider Trading
Michael S Anderson Net Worth
The estimated net worth of Michael S Anderson is at least $4 Million dollars as of 2024-11-05. Michael S Anderson is the CEO of Avadel Pharmaceuticals PLC and owns about 248,953 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $4 Million. Details can be seen in Michael S Anderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael S Anderson has not made any transactions after 2018-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael S Anderson
Michael S Anderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Anderson owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and National Healthcare Properties Inc (HTIA.PFD) .
Click here to see the complete history of Michael S Anderson’s form 4 insider trades.
Insider Ownership Summary of Michael S Anderson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AVDL | Avadel Pharmaceuticals PLC | 2018-08-10 | director & Chief Executive Officer |
HTIA.PFD | National Healthcare Properties Inc | 2023-09-12 | Chief Executive Officer |
Michael S Anderson Latest Holdings Summary
Michael S Anderson currently owns a total of 1 stock. Michael S Anderson owns 248,953 shares of Avadel Pharmaceuticals PLC (AVDL) as of August 10, 2018, with a value of $4 Million.
Latest Holdings of Michael S Anderson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AVDL | Avadel Pharmaceuticals PLC | 2018-08-10 | 248,953 | 14.86 | 3,699,442 |
Holding Weightings of Michael S Anderson
Michael S Anderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Anderson has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 16,297 shares on August 10, 2018, which brought Michael S Anderson around $80,018.
Insider Trading History of Michael S Anderson
- 1
Michael S Anderson Trading Performance
GuruFocus tracks the stock performance after each of Michael S Anderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Anderson is -10.46%. GuruFocus also compares Michael S Anderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Anderson within 3 months outperforms 1 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael S Anderson's insider trading performs compared to the benchmark.
Performance of Michael S Anderson
Michael S Anderson Ownership Network
Ownership Network List of Michael S Anderson
Ownership Network Relation of Michael S Anderson
Michael S Anderson Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Michael S Anderson is the director & Chief Executive Officer of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Michael S Anderson made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Michael S Anderson Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Anderson. You might contact Michael S Anderson via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.